API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com//news-release/2022/12/06/2568859/0/en/X4-Pharmaceuticals-Announces-Proposed-Public-Offering.html
https://www.globenewswire.com/news-release/2022/09/13/2515539/7767/en/MediciNova-Receives-a-Notice-of-Allowance-for-a-New-Patent-Covering-MN-001-and-MN-002-for-the-Treatment-of-Hypertriglyceridemia-Hypercholesterolemia-and-Hyperlipoproteinemia-in-Can.html
https://www.globenewswire.com/news-release/2022/08/09/2495425/7767/en/MediciNova-Announces-MN-001-tipelukast-Abstract-regarding-Improvement-of-Serum-Lipid-Panel-in-Type-2-Diabetes-and-NAFLD-Patients-Accepted-for-Presentation-at-the-IDF-2022-Congress-.html
https://www.globenewswire.com/news-release/2022/07/26/2485685/7767/en/MediciNova-Announces-Initiation-of-a-Phase-2-Trial-of-MN-001-tipelukast-in-NAFLD-with-Type-2-Diabetes-Mellitus-and-Hypertriglyceridemia.html
https://www.globenewswire.com/news-release/2022/06/22/2467556/7767/en/MediciNova-Announces-MN-001-tipelukast-Research-Collaboration-with-The-Juntendo-University-School-of-Medicine-in-Tokyo-Japan.html
https://www.globenewswire.com/news-release/2022/02/01/2376469/7767/en/MediciNova-Receives-a-New-Patent-Covering-MN-001-for-the-Treatment-of-Hypertriglyceridemia-Hypercholesterolemia-and-Hyperlipoproteinemia-in-Korea.html
https://www.globenewswire.com/news-release/2022/01/26/2373312/7767/en/MediciNova-Receives-a-Notice-of-Intention-to-Grant-for-a-New-Patent-Covering-MN-001-and-MN-002-for-Hepatic-Ballooning-in-Europe.html
https://www.globenewswire.com/news-release/2021/11/11/2333030/7767/en/MediciNova-Announces-MN-001-tipelukast-Data-regarding-Lipid-Metabolism-in-NASH-NAFLD-to-be-Presented-at-The-Liver-Meeting-2021-the-Annual-Meeting-of-the-American-Association-for-th.html
https://www.globenewswire.com/news-release/2020/11/13/2126186/0/en/MediciNova-Announces-Presentation-of-Positive-Findings-on-MN-001-tipelukast-in-Acute-Liver-Injury-Model-at-The-Liver-Meeting-Digital-Experience-2020.html
http://www.globenewswire.com/news-release/2020/02/17/1985882/0/en/MediciNova-Receives-Notice-of-Allowance-for-New-Patent-Covering-MN-001-and-MN-002-for-the-Treatment-of-Advanced-NASH-in-Japan.html
https://www.globenewswire.com/news-release/2020/01/27/1975807/0/en/MediciNova-Receives-Notice-of-Intention-to-Grant-for-New-Patent-Covering-MN-001-for-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis-in-Europe.html